Rajarajeswari Sivalenka

Rajarajeswari Sivalenka currently serves as Senior Director of Bioprocess Development at Celularity Inc., focusing on degenerative disease research and development since June 2020. Previously held roles include Director and Principal Scientist at AssayCell Technologies, and Principal Owner at Celularity, Inc. Additional experience includes a Senior Scientist position at Celgene and Senior Research Biochemist at Vantage Specialty Ingredients, Inc. Rajarajeswari has also contributed as Research Faculty at the Icahn School of Medicine at Mount Sinai and as a Postdoctoral Research Associate at both UVA Health and the Centre for Cellular and Molecular Biology. Educational achievements include a Mini-MBA in BioPharma Innovation from Rutgers University and a PhD in Biochemistry from Osmania University, alongside an MSc in Biotechnology from the University of Hyderabad.